TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026

Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study.

David A Sallman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.